Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
XPO
XPO
$22.3B
| $66.8M | 0.1% |
3,387,661
+898,321
| +36% | +$24.9M |
|
|
PRMW
252
DELISTED
Primo Water Corporation
PRMW
| $66.5M | 0.1% |
4,771,389
-589,091
| -11% | -$8.67M |
|
253
Tenaris
TS
$26.8B
| $66.4M | 0.1% |
3,116,490
+569,534
| +22% | +$15.8M |
|
254
Teck Resources
TECK
$34.1B
| $65.2M | 0.1% |
3,025,877
+1,004,095
| +50% | +$21.8M |
|
255
Steris
STE
$23B
| $64.9M | 0.1% |
607,474
+568,469
| +1,457% | +$63.5M |
|
256
Viatris
VTRS
$18.9B
| $64.4M | 0.1% |
2,350,928
-288,092
| -11% | -$9.33M |
|
257
Wyndham Hotels & Resorts
WH
$5.47B
| $64.2M | 0.1% |
1,414,188
+1,131,716
| +401% | +$54.9M |
|
258
Ross Stores
ROST
$75.9B
| $64.1M | 0.1% |
770,813
+690,807
| +863% | +$62.5M |
|
259
ICU Medical
ICUI
$4.53B
| $64.1M | 0.1% |
279,161
-260,478
| -48% | -$64.2M |
|
260
FMC
FMC
$1.41B
| $64.1M | 0.1% |
999,050
+875,839
| +711% | +$61.4M |
|
|
ALXN
261
DELISTED
Alexion Pharmaceuticals
ALXN
| $64M | 0.1% |
+657,816
| New | +$77.8M |
|
262
Accenture
ACN
$114B
| $63.6M | 0.1% |
+450,702
| New | +$71.3M |
|
263
KLA
KLAC
$236B
| $63.4M | 0.1% |
7,087,550
-6,140,210
| -46% | -$57.2M |
|
|
JWN
264
DELISTED
Nordstrom
JWN
| $63M | 0.1% |
1,350,660
-227,499
| -14% | -$12.8M |
|
265
American Airlines Group
AAL
$8.98B
| $62.3M | 0.1% |
1,938,870
-67,601
| -3% | -$2.35M |
|
266
First Citizens BancShares
FCNCA
$24.7B
| $61.8M | 0.1% |
163,973
-35,386
| -18% | -$14.9M |
|
|
PDCE
267
DELISTED
PDC Energy, Inc.
PDCE
| $61.6M | 0.1% |
2,071,379
+1,999,768
| +2,793% | +$80.3M |
|
|
SCHW
268
Charles Schwab
SCHW
$196B
| $61.6M | 0.1% |
1,483,370
+241,059
| +19% | +$10.9M |
|
269
Salesforce
CRM
$171B
| $61.5M | 0.1% |
448,794
-775,516
| -63% | -$107M |
|
270
Coca-Cola Europacific Partners
CCEP
$48.4B
| $61.4M | 0.1% |
1,338,063
-1,028,213
| -43% | -$47.6M |
|
|
GTLS
271
DELISTED
Chart Industries
GTLS
| $61.2M | 0.1% |
941,326
+802,977
| +580% | +$53M |
|
|
DRE
272
DELISTED
Duke Realty Corp.
DRE
| $61.2M | 0.1% |
2,363,114
+1,508,876
| +177% | +$41.9M |
|
273
Bloomin' Brands
BLMN
$975M
| $61.2M | 0.1% |
3,419,599
-951,683
| -22% | -$18.7M |
|
274
Molson Coors Class B
TAP
$8.06B
| $61.1M | 0.1% |
1,087,725
+6,455
| +0.6% | +$397K |
|
|
PRAH
275
DELISTED
PRA Health Sciences, Inc.
PRAH
| $61M | 0.1% |
663,570
+501,305
| +309% | +$50.7M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.